Aerosolised prostacyclin in adult respiratory distress syndrome
- PMID: 8105216
- DOI: 10.1016/0140-6736(93)92004-d
Aerosolised prostacyclin in adult respiratory distress syndrome
Abstract
We studied the effects of aerosolised prostacyclin (PGI2) in three patients with acute severe adult respiratory distress syndrome. 17-50 ng/kg per min, nebulised into the afferent limb of the ventilator circuit, decreased mean pulmonary artery pressure (SEM) from 40.3 (13.5) to 32.0 (3.8) mm Hg (pulmonary vascular resistance fell by 30%); systemic arterial pressure decreased slightly from 76.8 (2.2) to 74.5 (6.1) mm Hg. Concomitantly, the ratio of arterial oxygen partial pressure to the fraction of inspired oxygen increased from 120 (19) to 173 (18), mainly due to redistribution of blood flow from shunt areas to regions of normal ventilation-perfusion. All effects were reversed on drug withdrawal.
Comment in
-
Inhalational agents for pulmonary hypertension.Lancet. 1993 Oct 16;342(8877):941-2. doi: 10.1016/0140-6736(93)91996-y. Lancet. 1993. PMID: 8105208 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
